Disease modifying agents capable of controlling obesity with meaningful metabolic improvement have reshaped expectations for both clinicians and patients ( Nausea and vomiting remain among the most frequent and disruptive adverse effects across Glucagon-like peptide (GLP-1)-based therapies ( In this opinion article, we examine the mechanisms underlying nausea and vomiting in semaglutide, CagriSema, survodutide, tirzepatide, retatrutide, and orforglipron and situate them within obesity clinical practice ( We also propose practical strategies to mitigate gastrointestinal intolerance
Leaky gut syndrome , irritable bowel syndrome (IBS) , and Crohns disease are chronic conditions marked by inflammation and damage to the intestinal lining
Currently, there are no established guidelines for the precise Glutathione IV dosage for skin whitening, nor is there any definitive recommendation regarding the treatment duration
The backstory: In March 2023, the TEA said it intended to assign a team of conservators to oversee AISD's special education services, in particular a troubling district-wide backlog of initial evaluations, prompting the district to request an informal review
Other warnings If the patient has any persisting illness or alarm symptoms like weight loss, vomiting, dysphagia, haematemesis, or melena, this drug should be avoided
Swapping processed snacks for fresh fruit and yogurt is a simple change with measurable benefit
